object
investig
associ
cluster
differenti
gene
polymorph
suscept
acut
brucellosi
iranian
popul
method
studi
includ
iranian
patient
activ
brucellosi
healthi
individu
control
group
genotyp
variant
perform
use
amplif
refractori
mutat
systempolymeras
chain
reaction
method
result
preval
tt
ct
genotyp
associ
increas
risk
brucellosi
odd
ratio
confid
interv
ci
p
ct
ci
p
tt
genotyp
addit
minor
allel
significantli
frequent
present
brucellosi
patient
control
vs
respect
risk
factor
brucellosi
ci
p
conclus
find
provid
suggest
evid
associ
gene
polymorph
suscept
acut
brucellosi
iranian
popul
brucellosi
malta
fever
gibraltar
fever
cypru
fever
danub
fever
undul
fever
mediterranean
fever
bang
diseas
one
frequent
zoonot
infect
worldwid
transmit
human
eat
contamin
unpasteur
dairi
product
direct
contact
infect
anim
inhal
infect
aerosol
particl
major
case
aris
mediterranean
countri
europ
africa
mexico
central
south
america
india
central
asia
middl
east
includ
iran
brucella
spp
pleomorph
gramneg
nonsporeform
coccobacillu
bacteria
caus
sever
debilit
disabl
diseas
accompani
manifest
fever
weak
sweat
weight
loss
headach
persist
joint
pain
neurolog
complic
endocard
testicular
bone
abscess
format
brucella
spp
facult
intracellular
bacteria
abil
evad
kill
mechan
immun
system
multipli
within
organ
frequent
macrophag
liver
spleen
lung
bone
marrow
synovium
reticuloendotheli
system
among
speci
brucella
genu
three
speci
includ
brucella
melitensi
brucella
abortu
brucella
sui
commonli
associ
human
diseas
cluster
differenti
glycosylphosphatidylinositolanchor
molecul
mainli
express
cell
membran
surfac
monocytemacrophag
lineag
act
pattern
recognit
receptor
innat
immun
detect
varieti
ligand
bacteri
product
microbi
cell
wall
compon
even
whole
bacteria
particularli
specif
receptor
lipopolysaccharid
lp
gramneg
bacteria
lp
major
compon
outer
membran
gramneg
bacteria
call
bacteri
endotoxin
lp
main
virul
factor
brucella
role
cell
entri
immun
evas
infect
cell
lp
also
abil
induc
product
interleukin
il
result
promot
helper
th
respons
inhibit
respons
host
coreceptor
tolllik
receptor
tlr
togeth
form
complex
activ
innat
immun
system
start
varieti
effector
function
includ
secret
proinflammatori
cytokin
tumor
necrosi
factora
nitric
oxid
oxygen
radic
complement
compon
well
cell
prolifer
subsequ
bind
lp
nevertheless
high
product
molecul
may
caus
intens
harm
consequ
includ
sever
inflammatori
respons
septic
shock
death
moreov
solubl
type
produc
monocyt
hepatocyt
endotheli
cell
present
circul
bodi
fluid
deriv
secret
enzymat
cleav
glycosylphosphatidylinositolanchor
membran
type
sinc
plasma
level
increas
inflamm
infect
believ
acutephas
protein
increas
sever
inflammatori
process
human
gene
locat
chromosom
sever
singl
nucleotid
polymorph
snp
includ
identifi
promot
region
gene
one
extens
studi
snp
includ
substitut
c
result
elev
transcript
activ
express
level
thu
far
gene
polymorph
examin
sever
inflammatori
infecti
diseas
includ
tuberculosi
brucellosi
chlamydia
pneumonia
infect
helicobact
pylori
infect
hepat
b
c
sever
acut
respiratori
syndrom
result
inconsist
conflict
therefor
current
studi
aim
evalu
possibl
associ
gene
polymorph
suscept
acut
brucellosi
iranian
popul
current
casecontrol
retrospect
studi
includ
patient
men
women
suffer
activ
brucellosi
age
rang
year
old
mean
sd
healthi
individu
control
group
men
women
age
rang
year
mean
sd
blood
sampl
particip
collect
edtacontain
tube
dna
isol
take
inform
consent
patient
healthi
individu
patient
either
milk
farmer
includ
diagnos
infect
anim
histori
consum
raw
milk
unpasteur
dairi
product
demograph
characterist
patient
clinic
complic
shown
tabl
brucellosi
diagnos
accord
clinic
manifest
includ
fever
night
sweat
weak
malais
weight
loss
splenomegali
lymphadenophathi
myalgia
arthralgia
posit
blood
cultur
describ
previous
control
group
includ
healthi
blood
donor
evid
brucellosi
genet
disord
match
age
sex
geograph
area
control
subject
background
patient
risk
exposur
brucellosi
brucella
spp
cultiv
sheep
bloodagar
plate
incub
c
contact
co
condit
h
typic
wellisol
brucella
like
coloni
tini
transpar
rais
convex
entir
edg
smooth
glisten
surfac
along
streak
line
examin
macroscop
gram
stain
serolog
test
defin
wright
titr
plu
mercaptoethanol
test
coomb
wright
certifi
brucellosi
infect
complet
detail
organ
identif
method
describ
previous
paper
research
team
genom
dna
extract
peripher
blood
leukocyt
saltingout
method
explain
previous
qualiti
isol
dna
check
electrophoresi
agaros
gel
quantit
spectrophotometr
store
c
still
use
snp
genotyp
use
amplif
refractori
mutat
systempolymeras
chain
reaction
method
describ
previous
karhukorpi
et
al
allelespecif
singletub
polymeras
chain
reaction
method
use
four
primer
includ
two
allel
specif
primer
cfor
c
allel
trev
allel
two
outer
primer
control
band
addit
mismatch
insert
penultim
nucleotid
underlin
allelespecif
primer
increas
specif
pcr
reaction
primer
sequenc
follow
cfor
ctc
cag
aat
cct
tcc
tgt
tac
trev
tgt
agg
atg
ttt
cag
gga
ggg
ttg
gtg
cca
aca
gat
gag
gtt
ttc
ttt
cct
aca
cag
cgg
cac
pcr
condit
polymorph
follow
initi
denatur
c
min
cycl
c
c
c
min
final
extens
step
proceed
c
min
pcr
product
separ
standard
electrophoresi
agaros
gel
contain
ethidium
bromid
pcr
product
includ
bp
band
allel
bp
band
c
allel
bp
band
control
statist
analys
perform
appli
spss
softwar
window
version
spss
inc
chicago
il
usa
associ
among
genotyp
brucellosi
calcul
reckon
odd
ratio
confid
interv
ci
logist
regress
analys
p
valu
consid
statist
signific
hardyweinberg
equilibrium
test
c
test
snp
consider
polymorph
success
genotyp
brucellosi
patient
control
subject
deviat
hardyweinberg
equilibrium
observ
studi
case
control
group
p
genotyp
allel
frequenc
snp
studi
group
shown
tabl
result
show
polymorph
associ
risk
brucellosi
popul
genotyp
level
ct
tt
genotyp
frequent
patient
group
compar
case
associ
increas
risk
brucellosi
codomin
model
ci
p
ct
ci
p
tt
genotyp
addit
ct
tt
vs
cc
genotyp
domin
model
risk
factor
brucellosi
ci
p
likewis
recess
model
tt
genotyp
vs
cc
ct
associ
risk
brucellosi
ci
p
allel
level
minor
allel
significantli
frequent
present
brucellosi
patient
control
vs
respect
risk
factor
brucellosi
ci
p
studi
provid
data
associ
one
import
snp
flank
region
gene
acut
brucellosi
use
genotyp
analysi
result
show
preval
homozygot
tt
genotyp
well
allel
much
higher
brucellosi
patient
control
vs
vs
respect
carrier
tt
genotyp
allel
higher
risk
brucellosi
respect
cc
genotyp
c
allel
sever
studi
conduct
show
impact
snp
risk
infecti
diseas
best
knowledg
one
studi
assess
associ
polymorph
brucellosi
haidari
et
al
studi
brucellosi
western
iranian
popul
shown
frequenc
tt
genotyp
higher
patient
control
vs
suggest
homozygous
allel
promot
gene
may
confer
increas
risk
brucellosi
support
find
moreov
result
regard
polymorph
agreement
sever
infecti
studi
pulmonari
tuberculosi
c
pneumonia
infect
contrast
studi
report
associ
snp
chlamydia
trachomati
infect
campylobact
jejuni
infect
sever
acut
respiratori
syndrom
brucella
speci
highli
virul
caus
acut
infect
host
lp
bacterium
one
essenti
compon
first
step
establish
intracellular
replic
nich
brucella
surviv
multipli
lp
potent
stimul
monocyt
macrophag
activ
macrophag
one
earli
event
innat
immun
intracellular
pathogen
highaffin
receptor
bacteri
lp
express
mainli
cell
monocytemacrophag
lineag
bind
lp
result
cellular
activ
initi
rang
effector
function
includ
tabl
genotyp
allel
frequenc
snp
brucellosi
patient
control
allel
cytokin
secret
cell
prolifer
coreceptor
tlr
transfer
lp
signal
complex
engag
complex
result
activ
innat
immun
mechan
releas
proinflammatori
cytokin
subsequ
sever
inflammatori
respons
well
wors
circumst
septic
shock
death
studi
perform
explain
impact
snp
protein
express
polymorph
locat
gc
box
close
transcript
start
site
serv
bind
site
transcript
factor
involv
regul
gene
transcript
variant
snp
associ
high
express
surfac
monocyt
macrophag
increas
inflammatori
respons
thu
snp
could
genet
factor
interindividu
differ
suscept
infecti
diseas
like
brucellosi
result
highlight
role
inflammatori
respons
effect
promot
polymorph
host
immun
defens
conclus
studi
provid
evid
ct
tt
genotyp
may
serv
risk
factor
brucellosi
infect
popul
studi
larger
popul
differ
ethnic
requir
valid
find
inclus
understand
basic
mechan
underli
infect
pathogenesi
may
lead
develop
applic
effici
product
treatment
brucellosi
author
declar
conflict
interest
